Results 261 to 270 of about 517,391 (323)

Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models

Advanced Science, EarlyView.
Magnetoelectric nanoparticles (MENPs) serve as externally controlled, MRI‐activated theranostic agents for targeted cancer therapy by inducing electric field‐based ablation in solid tumors. MENPs enable simultaneous precise tumor ablation and MRI signal modulation, allowing real‐time treatment monitoring and prediction of therapeutic outcomes with no ...
John Michael Bryant, Max Shotbolt, Emmanuel Stimphil, Victoria Andre, Elric Zhang, Veronica Estrella, Kazim Husain, Joseph Weygand, Doug Marchion, Alex Sebastian Lopez, Dominique Abrahams, Shawnus Chen, Mostafa Abdel‐Mottaleb, Skye Conlan, Ibrahim Oraiqat, Vaseem Khatri, Jose Alejandro Guevara, Shari Pilon‐Thomas, Gage Redler, Kujtim Latifi, Natarajan Raghunand, Kosj Yamoah, Sarah Hoffe, James Costello, Jessica M. Frakes, Ping Liang, Robert A. Gatenby, Mokenge Malafa, Sakhrat Khizroev   +28 more
wiley   +1 more source

Characteristics and survival of adults with differentiated thyroid cancer in a Peruvian hospital. [PDF]

Rev Peru Med Exp Salud Publica
Morales-Concha L, Huamani-Linares I, Saihua-Palomino K, Luque Florez E, Chávez Echevarría A, Tupayachi Palomino RJ, Zea Nuñez CA, Mejia CR, Atamari-Anahui N.   +8 more
europepmc   +1 more source

RPSLearner: A Novel Approach Based on Random Projection and Deep Stacking Learning for Categorizing Non‐Small Cell Lung Cancer

Advanced Intelligent Systems, EarlyView.
Identifying non‐small cell lung cancer (NSCLC) subtypes is essential for precision cancer treatment. Conventional methods are laborious, or time‐consuming. To address these concerns, RPSLearner is proposed, which combines random projection and stacking ensemble learning for accurate NSCLC subtyping. RPSLearner outperforms state‐of‐the‐art approaches in
Xinchao Wu, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

[Community activities carried out in Primary Care in Galicia between 2018 and 2022: A descriptive study]. [PDF]

Aten Primaria
Mosteiro-Miguéns DG, Zapata-Cachafeiro M, Novío-Mallón S, Alfonso-González T, De Bernardo-Roca D, Rodríguez-Fernández A.   +5 more
europepmc   +1 more source

O Ninho: Repositório Institucional do Instituto Nacional de Câncer do Brasil como ferramenta digital de disseminação de informações oncológicas em acesso aberto

Martins, Robson Dias
openalex   +1 more source

RanBALL: An Ensemble Machine Learning Framework for Accurate Subtype Identification of Pediatric B‐Cell Acute Lymphoblastic Leukemia

Advanced Intelligent Systems, EarlyView.
Here, we present RanBALL, an ensemble random projection‐based model for accurate and cost‐effective identification of B‐cell acute lymphoblastic leukemia subtypes is presented. By preserving patient‐to‐patient distance after dimension reduction by random projection and ensemble learning, RanBALL can facilitate the discovery of B‐ALL subtype‐specific ...
Lusheng Li, Hanyu Xiao, Xinchao Wu, Zhenya Tang, Joseph D. Khoury, Jieqiong Wang, Shibiao Wan   +6 more
wiley   +1 more source

Predictive Models of Atherogenic Risk in Citizens of Trujillo (Peru) Based on Associated Factors. [PDF]

Nutrients
Bustamante Gallo JDP, Neglia Cermeño CS, Díaz-Ortega JL, Yupari-Azabache IL.   +3 more
europepmc   +1 more source

ESTUDO EPIDEMIOLÓGICO DO CÂNCER DE PELE: DADOS DO INSTITUTO NACIONAL DE CÂNCER

, 2019
Ivana Aparecida Mendes Veloso, Jânio Eduardo Siqueira, Daniel Silva Moraes, Hanna Beatriz Bacelar Tibães   +3 more
openalex   +1 more source

Supervivencia de cáncer cervicouterino escamoso y adenocarcinoma en pacientes atendidas en el Instituto Nacional del Cáncer, 2009-2013

, 2016
Michael Villalobos C., Carolina Wendling C., Claudia Sierra H., Ó. Valencia C., M. Cárcamo I., P. Gayán P.   +5 more
semanticscholar   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

American Journal of Hematology, EarlyView.
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth, Wilma Barcellini, Christine Ademokun, Junho Jang, Maria Luisa Lozano, David Valcarcel Ferreiras, Cristina Pascual‐Izquierdo, Shripad Chitnis, Sofiya Matviykiv, Alessandra Vitaliti, Chi Chen, Vasiliki Katsanou, Raghav Chawla, Hanny Al‐Samkari   +13 more
wiley   +1 more source